BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18677798)

  • 1. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Blake JA
    N Engl J Med; 2008 Jul; 359(5):531; author reply 532-3. PubMed ID: 18677798
    [No Abstract]   [Full Text] [Related]  

  • 2. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Eichhorn EJ
    N Engl J Med; 2008 Jul; 359(5):529-30; author reply 532. PubMed ID: 18677795
    [No Abstract]   [Full Text] [Related]  

  • 3. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Connor WE
    N Engl J Med; 2008 Jul; 359(5):530; author reply 532-3. PubMed ID: 18677797
    [No Abstract]   [Full Text] [Related]  

  • 4. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Steinberg D
    N Engl J Med; 2008 Jul; 359(5):529; author reply 532. PubMed ID: 18669434
    [No Abstract]   [Full Text] [Related]  

  • 5. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Diamond GA; Kaul S
    N Engl J Med; 2008 Jul; 359(5):530; author reply 532. PubMed ID: 18677796
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholesterol lowering and ezetimibe.
    Drazen JM; Jarcho JA; Morrissey S; Curfman GD
    N Engl J Med; 2008 Apr; 358(14):1507-8. PubMed ID: 18376001
    [No Abstract]   [Full Text] [Related]  

  • 7. Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?
    Brown BG; Taylor AJ
    N Engl J Med; 2008 Apr; 358(14):1504-7. PubMed ID: 18376002
    [No Abstract]   [Full Text] [Related]  

  • 8. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Kastelein JJ; Akdim F; Stroes ES; Zwinderman AH; Bots ML; Stalenhoef AF; Visseren FL; Sijbrands EJ; Trip MD; Stein EA; Gaudet D; Duivenvoorden R; Veltri EP; Marais AD; de Groot E;
    N Engl J Med; 2008 Apr; 358(14):1431-43. PubMed ID: 18376000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial.
    Kastelein JJ; Sager PT; de Groot E; Veltri E
    Am Heart J; 2005 Feb; 149(2):234-9. PubMed ID: 15846260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Kaye T
    N Engl J Med; 2008 Jul; 359(5):531-2; author reply 532-3. PubMed ID: 18677800
    [No Abstract]   [Full Text] [Related]  

  • 11. Is carotid intima-media thickness a reliable clinical predictor?
    Spence JD
    Mayo Clin Proc; 2008 Nov; 83(11):1299-300; author reply 1300-1. PubMed ID: 18990332
    [No Abstract]   [Full Text] [Related]  

  • 12. Carotid intima-media thickness (cIMT): a useful clinic tool or research luxury? Another view of the ENHANCE trial.
    Toutouzas P; Richter D
    Angiology; 2008; 59(2 Suppl):77S-9S. PubMed ID: 18628278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Commentary to the article: Kastelein JJ, Akdim F, Stroes ES, et al.; ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008; 358: 1431-43 ].
    Michałek A
    Kardiol Pol; 2008 May; 66(5):597-8, discussion 598-9. PubMed ID: 18630396
    [No Abstract]   [Full Text] [Related]  

  • 14. Making sense of ENHANCE: ezetimibe (Zetia) lowers LDL cholesterol but doesn't decrease carotid intima-media thickness.
    Smith D
    Mt Sinai J Med; 2008; 75(2):143-7. PubMed ID: 18500716
    [No Abstract]   [Full Text] [Related]  

  • 15. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 16. Statin therapy with ezetimibe or niacin in high-risk patients.
    Kastelein JJ; Bots ML
    N Engl J Med; 2009 Nov; 361(22):2180-3. PubMed ID: 19915218
    [No Abstract]   [Full Text] [Related]  

  • 17. The significance of femoral intima-media thickness and plaque scoring in the Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) study.
    van Wissen S; Smilde TJ; de Groot E; Hutten BA; Kastelein JJ; Stalenhoef AF
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):451-5. PubMed ID: 14671468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a problem with ezetimibe or just ENHANCEd hype?
    Whayne TF
    Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
    Int Angiol; 2011 Jun; 30(3):295; author reply 296. PubMed ID: 21617615
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholesterol absorption inhibitors in the treatment of hyperlipidemia: clinical outcomes in large clinical trials.
    Kesäniemi A
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():29-30. PubMed ID: 18001318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.